Modelling the Anti-Migraine Effects of BIBN 4096 BS: A New Calcitonin Gene-Related Peptide Receptor Antagonist

By Trocóniz Iñaki F.  

Clinical Pharmacokinetics, Vol. 45, Iss. 7, 2006-01 ,pp. : 715-728

Adis International

Access to resources Recommend Favorite

Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig

By Kapoor K.   Arulmani U.   Heiligers J.P.C.   Willems E.W.   Doods H.   Villalon C.M.   Saxena P.R.  

European Journal of Pharmacology, Vol. 475, Iss. 1, 2003-08 ,pp. : 69-77

Elsevier

Access to resources Recommend Favorite

Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells

By Edvinsson L.   Alm R.   Shaw D.   Rutledge R.Z.   Koblan K.S.   Longmore J.   Kane S.A.  

European Journal of Pharmacology, Vol. 434, Iss. 1, 2002-01 ,pp. : 49-53

Elsevier

Access to resources Recommend Favorite

Binding properties of the novel, non-peptide CGRP receptor antagonist radioligand, [ 3 H]BIBN4096BS

By Schindler M.   Doods H.N.  

European Journal of Pharmacology, Vol. 442, Iss. 3, 2002-05 ,pp. : 187-193

Elsevier

Access to resources Recommend Favorite

Clinical pharmacology of topiramate in migraine prevention

By Ferrari Anna   Tiraferri Ilaria   Neri Laura   Sternieri Emilio  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1169-1181

Informa Healthcare

Access to resources Recommend Favorite